Septa Pharmaceuticals Inc. adquiere CeeNU® (Lomustina) de Bristol Myers Squibb, Canadá
15-07-2026 13:00 via prnewswire.com

Septa Pharmaceuticals Inc. adquiere CeeNU® (Lomustina) de Bristol Myers Squibb, Canadá

MISSISSAUGA, ON, 15 de julio de 2026 /PRNewswire/ -- Septa Pharmaceuticals Inc., empresa líder en rápido crecimiento en el sector sanitario canadiense, se complace en anunciar la exitosa adquisición de CeeNU® (Lomustina) de Bristol Myers Squibb, Canadá, a partir del 29 de junio de 2026....
Read more »

PR Public relations news



New History Book Explores the Beginnings of Baptist Ministry in Vietnam, 1959-1975
New History Book Explores the Beginnings of Baptist Ministry in Vietnam, 1959-1975
Saitech Configures Multi-Million-Dollar NVIDIA Blackwell AI Infrastructure for a Global Financial Technology Company
Saitech Configures Multi-Million-Dollar NVIDIA Blackwell AI Infrastructure for a Global Financial Technology Company
Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies
Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies
REPT BATTERO bleibt im ersten Halbjahr 2026 weltweit die Nummer 1 bei den Auslieferungen von Batteriezellen für Heimspeicher
REPT BATTERO bleibt im ersten Halbjahr 2026 weltweit die Nummer 1 bei den Auslieferungen von Batteriezellen für Heimspeicher
Manufacturing Benchmarking Survey Highlights Cost Pressures and 2026 Growth Outlook
Manufacturing Benchmarking Survey Highlights Cost Pressures and 2026 Growth Outlook
Peabody to Announce Results for the Quarter Ended June 30, 2026
Peabody to Announce Results for the Quarter Ended June 30, 2026
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
Curaleaf Expands Florida Presence with Edgewater Dispensary Opening
Curaleaf Expands Florida Presence with Edgewater Dispensary Opening
La actualización estratégica de la marca GENMA ofrece resultados sólidos
La actualización estratégica de la marca GENMA ofrece resultados sólidos
OVERSTOCK CO2 OPTICS FOR HIGH & LOW POWER LASERS
OVERSTOCK CO2 OPTICS FOR HIGH & LOW POWER LASERS
Coveo Announces Renewal of Normal Course Issuer Bid and Automatic Securities Purchase Plan
Coveo Announces Renewal of Normal Course Issuer Bid and Automatic Securities Purchase Plan
CONAGRA BRANDS REPORTS FOURTH QUARTER AND FULL YEAR RESULTS
CONAGRA BRANDS REPORTS FOURTH QUARTER AND FULL YEAR RESULTS
Conagra Brands Announces Quarterly Dividend Payment of $0.175 Per Share
Conagra Brands Announces Quarterly Dividend Payment of $0.175 Per Share
Borr Drilling Limited - Invitation to Webcast and Conference Call for Q2 2026 Results
Desktop versie